The genetic characterization of a foscarnet-resistant strain of varicella-zoster virus (VZV) that was isolated from a patient with AIDS is reported. Compared with the sequence of the Dumas reference strain, this strain, which was isolated from a patient in whom foscarnet treatment failed, had two point mutations. The emergence of one of the mutations, which includes a change from a glutamic acid to a lysine at position 512 in the DNA polymerase, suggests that this mutation is implicated in the VZV foscarnet resistance. The other mutation, which replaces serine 863 by a glycine, is also present in 2 susceptible strains -Oka and a wild-type isolate.
Varicella-zoster virus (VZV) can cause persistent and occato be resistant to foscarnet in vitro. The average IC 50 of foscarnet was 350 mM for the isolate compared with 88 mM for the sionally disseminated herpes zoster in patients with AIDS. Acyclovir is the first line of treatment for VZV infection in reference Oka strain that was evaluated in parallel. The mean IC 50 of foscarnet for the isolate was higher than that for 2 immunodeficient patients [1] . Since 1988, cases of herpes zoster and meningoradiculitis resistant to acyclovir have been desusceptible strains recovered from human immunodeficiency virus -infected patients who did not receive foscarnet [6] . scribed [2, 3] . Acyclovir-resistant VZV infection usually responds to foscarnet therapy [4] .
Herein, we report the genetic characterization of this foscarnet resistance. Foscarnet is a pyrophosphate analogue that inMost studies of VZV sensitivity to foscarnet have yielded conflicting results between clinical and in vitro resistance. Sahibits VZV DNA polymerase. To detect the emergence of mutations during treatment, we compared the sequence of the frin et al. [4] described a case of herpes zoster in a patient with AIDS, which responded to foscarnet despite altered in vitro DNA polymerase gene of the strain isolated after foscarnet failure to that of the reference strain Dumas. sensitivity. In contrast, 2 patients with in vitro -susceptible strains failed to respond to foscarnet: 1 had AIDS [4] and 1 had received a bone-marrow transplant [5] .
One case of clinical resistance to foscarnet with correspondMaterials and Methods ing in vitro resistance has been described in our laboratory [6] . In brief, a 28-year-old AIDS patient, who received intravenous The sample was sequenced on both strands. Mutations were conwho never received any antiviral drugs. This finding shows firmed on 2 other clones of the same strain.
that this mutation is not responsible for foscarnet resistance. tion is implicated in resistance. One drug-resistant VZV mutant exhibiting the same mutation has been mentioned [9] .
Results
By analogy with the DNA polymerase gene of herpes simplex virus, we situated the mutation at position 512 between Our PCR method allowed us to amplify a fragment of the the conserved regions IV and A described elsewhere [10 -12]. 3990 bp that contained the VZV DNA polymerase gene. ComAlthough outside a conserved region, this nonconservative mupared with the sequence of the Dumas strain [7] , the strain tation was located in a region common to all herpesviruses from the VZV isolate had three mutations: G to A at position ( figure 1 ). It has been demonstrated that the mutation causing 49103 of the complete genome and position 1534 of the DNA resistance of CMV to ganciclovir may be situated outside a polymerase gene, which entails a nonconservative change from conserved region of the DNA polymerase gene: The conservaan acidic amino acid (glutamic acid) to a basic amino acid tive substitution of a leucine by an isoleucine was also found (lysine) at position 512; A to G at position 48050 of the combetween conserved region IV and A and accounted for resisplete genome and position 2587 of the DNA polymerase gene, tance of mutant CMV strains to ganciclovir [13] . In other herwhich changed the serine at position 863 into a glycine; and pesviruses, substitution of a single amino acid in a conserved a silent mutation, T to C at position 49004 of the complete region of the DNA polymerase gene can cause resistance. Ingenome and position 1632 of the DNA polymerase gene.
deed, a single conservative or nonconservative mutation can lead to resistance of herpes simplex virus to foscarnet or phosDiscussion phonoacetic acid [9 -11]. The same phenomenon has been observed in ganciclovir-resistant CMV mutants derived from We have observed the genetic basis for a case of VZV CMV strain AD169 [13, 14] , and in isolates from patients resistance to foscarnet. Compared with the sequence of the resistant to ganciclovir and foscarnet [15] . Dumas reference strain, the sequence of the strain isolated after
We conclude that a single amino acid substitution at position foscarnet failure had two point mutations.
512 in the VZV DNA polymerase gene may confer resistance The mutation replacing serine 863 by a glycine in the VZV to foscarnet. However, a study of a larger number of strains strain we characterized as resistant was also present in 2 suscep-(foscarnet-resistant clinical isolates or laboratory mutants) will tible strains (data not shown), an Oka strain (a reference strain), and a wild-type isolate recovered from a patient with varicella be necessary to obtain a fuller picture of the genetic bases of 
